Source: U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee
Presentation date: 22 October 2020 (first emergency use authorization issued on 11 December 2020 in the USA)
Links: YouTube video at 2:33:40 or screen capture image
- Guillain-Barré syndrome 🧠
- Acute disseminated encephalomyelitis 🧠🛡
- Encephalitis/myelitis/encephalomyelitis/meningoencephalitis/meningitis/encephalopathy 🧠🛡☠️
- Convulsions/seizures 🧠
- Stroke 🧠❤️☠️
- Narcolepsy and cataplexy 🧠
- Anaphylaxis 🛡☠️
- Acute myocardial infarction (i.e. heart attack) ❤️☠️
- Myocarditis/pericarditis 🛡❤️☠️
- Autoimmune disease 🛡☠️
- Death (a kind of euthanasia, in this case) 🧠🛡❤️☠️
- Infertility, miscarriage and stillbirth 🛡☠️
- Other acute demyelinating diseases 🧠
- Non-anaphylactic allergic reactions 🛡☠️
- Thrombocytopenia ❤️☠️
- Disseminated intravascular coagulation ❤️☠️
- Venous thromboembolism ❤️☠️
- Arthritis and arthralgia (here are some examples from Isreal) 🛡
- Kawasaki disease 🛡
- Multi-system inflammatory syndrome in children 🛡☠️
- Vaccine enhanced disease (i.e. increased rate of infection, more severe illness) 🛡☠️
Legend:
🧠 nervous system
🛡immune system/inflammation
❤️ cardiovascular system
☠️ premature death
